Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-03-06 @ 7:39 AM
Study NCT ID:
NCT00910403
Status:
COMPLETED
Last Update Posted:
2011-05-26
First Post:
2009-05-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicenter Evaluation of Safety and Effectiveness of Presbyopic LASIK for Hyperopes
Sponsor:
Technolas Perfect Vision GmbH
Organization:
Study Overview
Official Title:
A Prospective Multicenter, Study to Evaluate the Safety and Effectiveness of the Presbyopia Algorithm for Hyperopia and Hyperopic Astigmatism Using LASIK
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PresbyLASIK
Brief Summary:
The Presbyopia Algorithm subject to this study has been specifically developed to prospectively generate a treatment file for the Technolas 217z100 laser that will provide Presbyopia correction among eyes with primary hyperopia or hyperopic astigmatism (distance correction). The treatment algorithm provides a bilateral, multifocal ablation with a center near addition, thereby allowing good focus over a range of object distances.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: